3-(6-Trifluoromethyl-3-pyridinyl)-2-propenoic acid | 773131-93-4

• 物质功能分类: 医药中间体 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 3-(6-Trifluoromethyl-3-pyridinyl)-2-propenoic acid
• 英文别名: 3-[6-(trifluoromethyl)pyridin-3-yl]prop-2-enoic acid
• CAS: 773131-93-4
• 化学式: C₉H₆F₃NO₂
• 分子量: 217.147
• InChiKey: ATQAZNAOJJOPTL-UHFFFAOYSA-N

物化性质

• 沸点：
  284.7±35.0 °C(Predicted)
• 密度：
  1.430

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  50.2
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  3-(6-Trifluoromethyl-3-pyridinyl)-2-propenoic acid 在 草酰氯 作用下， 以 四氢呋喃 为溶剂， 生成 3-[6-(Trifluoromethyl)pyridin-3-yl]prop-2-enoyl chloride
  参考文献：
  名称：

  N-Hydroxybenzimidazole inhibitors of ExsA MAR transcription factor in Pseudomonas aeruginosa: In vitro anti-virulence activity and metabolic stability

  摘要：

  ExsA is a multiple adaptational response (MAR) transcription factor, regulating the expression of a virulence determinant, the type III secretion system (T3SS) in Pseudomonas aeruginosa. Non-cytotoxic, non-antibacterial N-hydroxybenzimidazoles were identified as effective inhibitors of ExsA-DNA binding, and their potential utility as anti-virulence agents for P. aeruginosa was demonstrated in a whole cell assay. Select N-hydroxybenzimidazole inhibitors were stable in an in vitro human liver microsomal assay. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.04.014
• 作为产物：
  描述：

  Ethyl 3-[6-(trifluoromethyl)pyridin-3-yl]prop-2-enoate 在 水 、 sodium hydroxide 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 以75%的产率得到3-(6-Trifluoromethyl-3-pyridinyl)-2-propenoic acid
  参考文献：
  名称：

  Synthesis of novel tetrahydroisoquinoline bronchodilators

  摘要：

  The synthesis and bronchorelaxing effects of a series of novel tetrahydroisoquinoline amides are described. The compounds were evaluated for their ability to relax LTD4 contracted isolated human small airways ex-vivo. Several compounds demonstrated highly efficacious bronchorelaxing properties. Cinnamide 71 was selected for further studies and constitutes a promising candidate as a novel bronchorelaxing agent for the treatment of pulmonary disorders. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.07.057

文献信息

• Ligand-controlled divergent dehydrogenative reactions of carboxylic acids via C–H activation
  作者：Zhen Wang、Liang Hu、Nikita Chekshin、Zhe Zhuang、Shaoqun Qian、Jennifer X. Qiao、Jin-Quan Yu

  DOI：10.1126/science.abl3939

  日期：2021.12.3

  inaccessible with existing carbonyl desaturation protocols. Product inhibition is overcome through ligand-promoted preferential activation of C(sp3)–H bonds over C(sp2)–H bonds or a tandem dehydrogenation or vinyl C–H alkynylation sequence. The dehydrogenation reaction is compatible with molecular oxygen as the terminal oxidant.

  通过亚甲基 C-H 活化将烷基链脱氢转化为烯烃仍然是一个重大挑战。我们报道了两类吡啶-吡啶酮配体，它们通过钯催化的β-亚甲基C-H活化羧酸实现不同的脱氢反应，从而直接合成α,β-不饱和羧酸或γ-亚烷基丁烯内酯。这对反应的定向性质允许在其他烯醇化官能团（例如酮）存在下对羧酸进行化学选择性脱氢，从而提供现有羰基去饱和方案无法实现的化学选择性。通过配体促进的 C(sp 3 )–H 键相对于 C(sp 2 )–H 键的优先激活或串联脱氢或乙烯基 C–H 炔基化序列来克服产物抑制。脱氢反应与分子氧作为末端氧化剂相容。